Cite
Characterization of weakly hormone receptor (HR)-positive, HER- negative breast cancer (BC) and current treatment strategies
MLA
Kari B. Wisinski, and Johanna Poterala. “Characterization of Weakly Hormone Receptor (HR)-Positive, HER- Negative Breast Cancer (BC) and Current Treatment Strategies.” Journal of Clinical Oncology, vol. 38, May 2020, p. e12621. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c8987f8f444162d7ab89967085232450&authtype=sso&custid=ns315887.
APA
Kari B. Wisinski, & Johanna Poterala. (2020). Characterization of weakly hormone receptor (HR)-positive, HER- negative breast cancer (BC) and current treatment strategies. Journal of Clinical Oncology, 38, e12621.
Chicago
Kari B. Wisinski, and Johanna Poterala. 2020. “Characterization of Weakly Hormone Receptor (HR)-Positive, HER- Negative Breast Cancer (BC) and Current Treatment Strategies.” Journal of Clinical Oncology 38 (May): e12621. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c8987f8f444162d7ab89967085232450&authtype=sso&custid=ns315887.